[Photoprotection and its implications for drug safety].

Medycyna pracy Pub Date : 2024-11-28 Epub Date: 2024-11-08 DOI:10.13075/mp.5893.01560
Agata Kryczyk-Poprawa, Grzegorz Czarnecki, Katarzyna Jaśkiewicz
{"title":"[Photoprotection and its implications for drug safety].","authors":"Agata Kryczyk-Poprawa, Grzegorz Czarnecki, Katarzyna Jaśkiewicz","doi":"10.13075/mp.5893.01560","DOIUrl":null,"url":null,"abstract":"<p><p>Appropriate photoprotection plays a key role in the safety of using medicinal preparations whose active substances may induce photosensitivity reactions. This aspect applies not only to drugs applied topically to the skin, but also systemically. Drug-induced photosensitivity reactions to light depend on the active substance contained in the medicinal product and its dose, which translates into the concentration in the skin, the type of ultraviolet radiation, its intensity and exposure time. The chemical structure of phototoxic drugs contains unsaturated chemical bonds and aromatic groups, which are responsible for the absorption of radiation, the formation of degradation products and/or free radicals and hypersensitivity reactions. Therefore, in order to prevent hypersensitivity reactions, it is necessary to use appropriate sun protection and/or avoid exposure to solar radiation during pharmacotherapy with selected groups of drugs. The paper presents the latest research results on the impact of drug-induced photohypersensitivity on the increased likelihood of skin cancer. Drugs with the potential to induce photohypersensitivity reactions are discussed, including information on the relationship between their long-term use and the incidence of skin cancer. Based on the data contained in the Product Characteristics, exemplary indications regarding the appropriate photoprotection method to ensure the safe use of the medicinal product are presented. Med Pr Work Health Saf. 2024;75(5):475-484.</p>","PeriodicalId":101460,"journal":{"name":"Medycyna pracy","volume":" ","pages":"475-484"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medycyna pracy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13075/mp.5893.01560","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Appropriate photoprotection plays a key role in the safety of using medicinal preparations whose active substances may induce photosensitivity reactions. This aspect applies not only to drugs applied topically to the skin, but also systemically. Drug-induced photosensitivity reactions to light depend on the active substance contained in the medicinal product and its dose, which translates into the concentration in the skin, the type of ultraviolet radiation, its intensity and exposure time. The chemical structure of phototoxic drugs contains unsaturated chemical bonds and aromatic groups, which are responsible for the absorption of radiation, the formation of degradation products and/or free radicals and hypersensitivity reactions. Therefore, in order to prevent hypersensitivity reactions, it is necessary to use appropriate sun protection and/or avoid exposure to solar radiation during pharmacotherapy with selected groups of drugs. The paper presents the latest research results on the impact of drug-induced photohypersensitivity on the increased likelihood of skin cancer. Drugs with the potential to induce photohypersensitivity reactions are discussed, including information on the relationship between their long-term use and the incidence of skin cancer. Based on the data contained in the Product Characteristics, exemplary indications regarding the appropriate photoprotection method to ensure the safe use of the medicinal product are presented. Med Pr Work Health Saf. 2024;75(5):475-484.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[光保护及其对药物安全性的影响]。
适当的光防护对于安全使用活性物质可能诱发光敏反应的药物制剂起着关键作用。这不仅适用于皮肤局部用药,也适用于全身用药。药物引起的光敏反应取决于药物所含的活性物质及其剂量,即在皮肤中的浓度、紫外线辐射的类型、强度和照射时间。光毒性药物的化学结构中含有不饱和化学键和芳香族基团,它们是吸收辐射、形成降解产物和/或自由基以及超敏反应的原因。因此,为了预防超敏反应,有必要使用适当的防晒措施和/或在使用某些药物组进行药物治疗期间避免暴露在太阳辐射下。本文介绍了关于药物诱导的光过敏反应对增加皮肤癌发病几率的影响的最新研究成果。文中讨论了可能诱发光过敏反应的药物,包括长期使用这些药物与皮肤癌发病率之间关系的信息。根据 "产品特征 "中包含的数据,介绍了有关适当光防护方法的示例性说明,以确保安全使用该药品。Med Pr Work Health Saf.2024;75(5).
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Occupational anaphylaxis to food. [The changing epidemiology of tick-borne encephalitis: epidemic surveillance and disease prevention challenges]. [Exposure to bioaerosol in the residential environment]. [Assessment of the importance of teleradiology services in the opinion of electroradiologists in Poland]. [Breast cancer under control - risk calculators].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1